4.7 Article

Recompleting the Caenorhabditis elegans genome

Journal

GENOME RESEARCH
Volume 29, Issue 6, Pages 1009-1022

Publisher

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/gr.244830.118

Keywords

-

Funding

  1. U.S. Department of Agriculture [2010-65205-20361]
  2. NIFA-National Science Foundation (NSF) [IOS-0923812]
  3. Japan Science and Technology Corporation (CREST) [JPMJCR13W3]
  4. AMED (Japan Agency for Medical Research and Development, GRIFIN)
  5. National Institutes of Health (NIH) [GM37706/GM130366]
  6. NIH [AI111173, OD010440]
  7. Moore Foundation [4551]
  8. Cornell University
  9. Arnold O. Beckman Postdoctoral Fellowship
  10. Stanford Medicine Dean's Fellowship
  11. Helen Hay Whitney Postdoctoral Fellowship
  12. NSF XSEDE [TG-MCB180039]
  13. NIFA [2010-65205-20361, 581141] Funding Source: Federal RePORTER

Ask authors/readers for more resources

Caenorhabditis elegans was the first multicellular eukaryotic genome sequenced to apparent completion. Although this assembly employed a standard C. elegans strain (N2), it used sequence data from several laboratories, with DNA propagated in bacteria and yeast. Thus, the N2 assembly has many differences from any C. elegans available today. To provide a more accurate C. elegans genome, we performed long-read assembly of VC2010, a modern strain derived from N2. Our VC2010 assembly has 99.98% identity to N2 but with an additional 1.8 Mb including tandem repeat expansions and genome duplications. For 116 structural discrepancies between N2 and VC2010, 97 structures matching VC2010 (84%) were also found in two outgroup strains, implying deficiencies in N2. Over 98% of N2 genes encoded unchanged products in VC2010; more-over, we predicted >= 53 new genes in VC2010. The recompleted genome of C. elegans should be a valuable resource for genetics, genomics, and systems biology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available